Physician profile
Stacy Senn
NPI 1750442265
$3,375.45
in general payments reported to CMS, 2019-2025
14 companies · $842 in 2025
The $842 reported for 2025 was more than what 96% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $337 · 2022: $551 · 2023: $932 · 2024: $714 · 2025: $842.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,487.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Servier Pharmaceuticals LLC | $606.91 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $525.69 | 2021-2025 | |
| Genzyme Corporation | $372.02 | 2023-2025 | |
| Y-Mabs Therapeutics, INC. | $363.17 | 2022-2025 | Danyelza |
| Incyte Corporation | $248.39 | 2022-2023 | Jakafi |
| Novartis Pharmaceuticals Corporation | $234.34 | 2022-2024 | |
| Uswm, LLC | $218.24 | 2024-2025 | Iwilfin |
| Sobi, INC | $201.67 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $149.70 | 2023-2025 | |
| Fennec Pharmaceuticals, INC. | $126.89 | 2023 | Pedmark |
| Bayer Healthcare Pharmaceuticals INC. | $118.16 | 2021 | |
| Genentech USA, INC. | $104.62 | 2021 | |
| Day One Biopharmaceuticals | $91.48 | 2025 | Ojemda |
| Biotronik INC. | $14.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Senn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.